Label Changes for:

Elestrin (estradiol gel)

February 2012

Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.

February 2012

 

CONTRADICATIONS

Elestrin should not be used in women with any of the following conditions:
  • Known anaphylactic reaction or angioedema to Elestrin
  • Known protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders

 

WARNINGS AND PRECAUTIONS

Hereditary Angioedema
  • Exogenous estrogens may exacerbate symptoms of angioedema in women with hereditary angioedema
Hide
(web1)